Cadrenal Therapeutics sets 2024 Annual Meeting for July 29, 2024; updates stockholder proposal deadlines

Cadrenal Therapeutics, Inc.

Annual Meeting scheduled for July 29, 2024; record date set as June 6, 2024.
Stockholder proposals under Rule 14a-8 must be received by May 20, 2024.
Director nominations and other proposals not included in proxy also due by May 20, 2024.
Universal proxy rule compliance notice due by May 30, 2024 (60 days before meeting).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.